P. Legault

Biography

Pierre Legault has served as a member of the Company’s Board of Directors since January 2016 and has been Chairman of the Board of Directors since March 2016. He has over 35 years of experience working in the  pharmaceutical and biotechnology industry. Pierre Legault is also a director of Syndax   Pharmaceuticals and Armo Biosciences. In the past, he was a director at Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Regado Biosciences, Iroko Pharmaceuticals, Cyclacel Pharmaceuticals, Eckerd Pharmacy and NephroGenex, a biotechnology focused on kidney diseases, where he served from 2012 to 2016 as the Chairman and Chief Executive Officer. From 2010 to 2012, he served as the President and Chief Executive Officer of Prosidion Ltd., specialized in the treatment of diabetes and obesity. From 2009 to 2010, he served  as  the  Executive  Vice  President,  Chief  Financial  Officer  and  Treasurer  of  OSI  Pharmaceuticals. Mr. Legault  also  served  as  the President of Eckerd Pharmacy and Senior Executive Vice - President  of  Rite  Aid  Corporation. Between  1989  and  2005,  he  held  various  roles,  such  as  President, CEO and Chief  Financial  Officer,  at  legacy  companies  of  the  Sanofi - Aventis  group.  Mr.  Legault  holds  an  M.B.A.  in  Marketing  from McGill University and a Bachelor’s degree from HEC (France). He also studied at Harvard Business  School. He holds an MBA, BAA, CA, CPA and Six Sigma Green Belt diplomas. Pierre Legault has served as a member of the Company’s Board of Directors since January 2016 and has been Chairman of the Board of Directors since March 2016. He has over 35 years of experience working in the  pharmaceutical and biotechnology industry. Pierre Legault is also a director of Syndax   Pharmaceuticals and Armo Biosciences. In the past, he was a director at Tobira Therapeutics, NPS Pharmaceuticals, Forest Laboratories, Regado Biosciences, Iroko Pharmaceuticals, Cyclacel Pharmaceuticals, Eckerd Pharmacy and NephroGenex, a biotechnology focused on kidney diseases, where he served from 2012 to 2016 as the Chairman and Chief Executive Officer. From 2010 to 2012, he served as the President and Chief Executive Officer of Prosidion Ltd., specialized in the treatment of diabetes and obesity. From 2009 to 2010, he served  as  the  Executive  Vice  President,  Chief  Financial  Officer  and  Treasurer  of  OSI  Pharmaceuticals. Mr. Legault  also  served  as  the President of Eckerd Pharmacy and Senior Executive Vice - President  of  Rite  Aid  Corporation. Between  1989  and  2005,  he  held  various  roles,  such  as  President, CEO and Chief  Financial  Officer,  at  legacy  companies  of  the  Sanofi - Aventis  group.  Mr.  Legault  holds  an  M.B.A.  in  Marketing  from McGill University and a Bachelor’s degree from HEC (France). He also studied at Harvard Business  School. He holds an MBA, BAA, CA, CPA and Six Sigma Green Belt diplomas.

Research Interest

drug development from discovery screening